[HTML][HTML] Full-length P2X7 structures reveal how palmitoylation prevents channel desensitization
AE McCarthy, C Yoshioka, SE Mansoor - Cell, 2019 - cell.com
P2X receptors are trimeric, non-selective cation channels activated by extracellular ATP. The
P2X 7 receptor subtype is a pharmacological target because of involvement in apoptotic …
P2X 7 receptor subtype is a pharmacological target because of involvement in apoptotic …
[PDF][PDF] Full-Length P2X7 Structures Reveal How Palmitoylation Prevents Channel Desensitization
AE McCarthy, C Yoshioka, SE Mansoor - Cell, 2019 - researchgate.net
SUMMARY P2X receptors are trimeric, non-selective cation channels activated by
extracellular ATP. The P2X7 receptor subtype is a pharmacological target because of …
extracellular ATP. The P2X7 receptor subtype is a pharmacological target because of …
Full-Length P2X7 Structures Reveal How Palmitoylation Prevents Channel Desensitization
AE McCarthy, C Yoshioka, SE Mansoor - Cell, 2019 - pubmed.ncbi.nlm.nih.gov
P2X receptors are trimeric, non-selective cation channels activated by extracellular ATP. The
P2X 7 receptor subtype is a pharmacological target because of involvement in apoptotic …
P2X 7 receptor subtype is a pharmacological target because of involvement in apoptotic …
Full-Length P2X7 Structures Reveal How Palmitoylation Prevents Channel Desensitization
AE McCarthy, C Yoshioka, SE Mansoor - Cell, 2019 - ohsu.elsevierpure.com
P2X receptors are trimeric, non-selective cation channels activated by extracellular ATP. The
P2X 7 receptor subtype is a pharmacological target because of involvement in apoptotic …
P2X 7 receptor subtype is a pharmacological target because of involvement in apoptotic …
[引用][C] Full-Length P2X7 Structures Reveal How Palmitoylation Prevents Channel Desensitization
AE McCarthy, C Yoshioka, SE Mansoor - Cell, 2019 - cir.nii.ac.jp
[HTML][HTML] Full-length P2X7 structures reveal how palmitoylation prevents channel desensitization
AE McCarthy, C Yoshioka, SE Mansoor - Cell, 2019 - ncbi.nlm.nih.gov
SUMMARY P2X receptors are trimeric, non-selective cation channels activated by
extracellular ATP. The P2X 7 receptor subtype is a pharmacological target because of …
extracellular ATP. The P2X 7 receptor subtype is a pharmacological target because of …
Full-Length P2X7 Structures Reveal How Palmitoylation Prevents Channel Desensitization.
AE McCarthy, C Yoshioka, SE Mansoor - Cell, 2019 - xenbase.org
P2X receptors are trimeric, non-selective cation channels activated by extracellular ATP. The
P2X7 receptor subtype is a pharmacological target because of involvement in apoptotic …
P2X7 receptor subtype is a pharmacological target because of involvement in apoptotic …
Full-Length P2X7 Structures Reveal How Palmitoylation Prevents Channel Desensitization
AE McCarthy, C Yoshioka, SE Mansoor - paper.sciencenet.cn
P2X receptors are trimeric, non-selective cation channels activated by extracellular ATP. The
P2X7 receptor subtype is a pharmacological target because of involvement in apoptotic …
P2X7 receptor subtype is a pharmacological target because of involvement in apoptotic …
Full-Length P2X7 Structures Reveal How Palmitoylation Prevents Channel Desensitization.
AE McCarthy, C Yoshioka, SE Mansoor - Cell, 2019 - europepmc.org
SUMMARY P2X receptors are trimeric, non-selective cation channels activated by
extracellular ATP. The P2X 7 receptor subtype is a pharmacological target because of …
extracellular ATP. The P2X 7 receptor subtype is a pharmacological target because of …
[HTML][HTML] Full-Length P2X7 Structures Reveal How Palmitoylation Prevents Channel Desensitization
AE McCarthy, C Yoshioka, SE Mansoor - Cell, 2019 - Elsevier
P2X receptors are trimeric, non-selective cation channels activated by extracellular ATP. The
P2X 7 receptor subtype is a pharmacological target because of involvement in apoptotic …
P2X 7 receptor subtype is a pharmacological target because of involvement in apoptotic …